Clinical trial NCT03848533 - References

PreDiabetes — Effect of Melatonin and Metformin on Glycemic Control Genotoxicity and Cytotoxicity Markers in Patients With Prediabetes

Citation(s)

•   AIDS networking in Canada, US
  CMAJ. 1995 Dec 15;153(12):1772.
•   Al-Omary FA
  Melatonin: comprehensive profile. Profiles Drug Subst Excip Relat Methodol. 2013;38:159-226. doi: 10.1016/B978-0-12-407691-4.00005-8. Review.
•   American Diabetes Association
  2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2018. Diabetes Care. 2018 Jan;41(Suppl 1):S13-S27. doi: 10.2337/dc18-S002. Review.
•   Brannick B, Wynn A, Dagogo-Jack S
  Prediabetes as a toxic environment for the initiation of microvascular and macrovascular complications. Exp Biol Med (Maywood). 2016 Jun;241(12):1323-31. doi: 10.1177/1535370216654227. Review.
•   Brownlee M
  Biochemistry and molecular cell biology of diabetic complications. Nature. 2001 Dec 13;414(6865):813-20.
•   Brzezinski A
  Melatonin in humans. N Engl J Med. 1997 Jan 16;336(3):186-95. Review.
•   Dunn CJ, Peters DH
  Metformin. A review of its pharmacological properties and therapeutic use in non-insulin-dependent diabetes mellitus. Drugs. 1995 May;49(5):721-49. Review.
•   Ferrannini E, Gastaldelli A, Iozzo P
  Pathophysiology of prediabetes. Med Clin North Am. 2011 Mar;95(2):327-39, vii-viii. doi: 10.1016/j.mcna.2010.11.005. Review.
•   Gamboa ML, Canales-Gómez JS, Castro Sandoval T de J
  Bioavailability of Long Acting Capsules of Melatonin in Mexican Healthy Volunteers. J Bioequiv Availab. 2010 Sep 30;02(05).
•   Garfinkel D, Zorin M, Wainstein J, Matas Z, Laudon M, Zisapel N
  Efficacy and safety of prolonged-release melatonin in insomnia patients with diabetes: a randomized, double-blind, crossover study. Diabetes Metab Syndr Obes. 2011;4:307-13. doi: 10.2147/DMSO.S23904. Epub 2011 Aug 2.
•   Giacco F, Brownlee M
  Oxidative stress and diabetic complications. Circ Res. 2010 Oct 29;107(9):1058-70. doi: 10.1161/CIRCRESAHA.110.223545. Review.
•   Gong L, Goswami S, Giacomini KM, Altman RB, Klein TE
  Metformin pathways: pharmacokinetics and pharmacodynamics. Pharmacogenet Genomics. 2012 Nov;22(11):820-7. doi: 10.1097/FPC.0b013e3283559b22. Review.
•   Graham GG, Punt J, Arora M, Day RO, Doogue MP, Duong JK, Furlong TJ, Greenfield JR, Greenup LC, Kirkpatrick CM, Ray JE, Timmins P, Williams KM
  Clinical pharmacokinetics of metformin. Clin Pharmacokinet. 2011 Feb;50(2):81-98. doi: 10.2165/11534750-000000000-00000. Review.
•   Hostalek U, Gwilt M, Hildemann S
  Therapeutic Use of Metformin in Prediabetes and Diabetes Prevention. Drugs. 2015 Jul;75(10):1071-94. doi: 10.1007/s40265-015-0416-8. Review.
•   Hussain SA, Khadim HM, Khalaf BH, Ismail SH, Hussein KI, Sahib AS
  Effects of melatonin and zinc on glycemic control in type 2 diabetic patients poorly controlled with metformin. Saudi Med J. 2006 Oct;27(10):1483-8.
•   Jdey W, Thierry S, Popova T, Stern MH, Dutreix M
  Micronuclei Frequency in Tumors Is a Predictive Biomarker for Genetic Instability and Sensitivity to the DNA Repair Inhibitor AsiDNA. Cancer Res. 2017 Aug 15;77(16):4207-4216. doi: 10.1158/0008-5472.CAN-16-2693. Epub 2017 Jun 6.
•   Kisurina-Evgenieva OP, Sutiagina OI, Onishchenko GE
  Biogenesis of Micronuclei. Biochemistry (Mosc). 2016 May;81(5):453-64. doi: 10.1134/S0006297916050035. Review.
•   Lalau JD
  Lactic acidosis induced by metformin: incidence, management and prevention. Drug Saf. 2010 Sep 1;33(9):727-40. doi: 10.2165/11536790-000000000-00000. Review.
•   Lardone PJ, Alvarez-Sanchez SN, Guerrero JM, Carrillo-Vico A
  Melatonin and glucose metabolism: clinical relevance. Curr Pharm Des. 2014;20(30):4841-53. Review.
•   Lo CC, Lin SH, Chang JS, Chien YW
  Effects of Melatonin on Glucose Homeostasis, Antioxidant Ability, and Adipokine Secretion in ICR Mice with NA/STZ-Induced Hyperglycemia. Nutrients. 2017 Oct 29;9(11). pii: E1187. doi: 10.3390/nu9111187.
•   McMullan CJ, Schernhammer ES, Rimm EB, Hu FB, Forman JP
  Melatonin secretion and the incidence of type 2 diabetes. JAMA. 2013 Apr 3;309(13):1388-96. doi: 10.1001/jama.2013.2710.
•   Onaran I, Guven GS, Ozdas SB, Kanigur G, Vehid S
  Metformin does not prevent DNA damage in lymphocytes despite its antioxidant properties against cumene hydroperoxide-induced oxidative stress. Mutat Res. 2006 Dec 10;611(1-2):1-8. Epub 2006 Sep 26.
•   Park JH, Shim HM, Na AY, Bae KC, Bae JH, Im SS, Cho HC, Song DK
  Melatonin prevents pancreatic ß-cell loss due to glucotoxicity: the relationship between oxidative stress and endoplasmic reticulum stress. J Pineal Res. 2014 Mar;56(2):143-53. doi: 10.1111/jpi.12106. Epub 2013 Nov 25.
•   Reutrakul S, Sumritsopak R, Saetung S, Chanprasertyothin S, Chailurkit LO, Anothaisintawee T
  Lower nocturnal urinary 6-sulfatoxymelatonin is associated with more severe insulin resistance in patients with prediabetes. Neurobiol Sleep Circadian Rhythms. 2017 Jun 28;4:10-16. doi: 10.1016/j.nbscr.2017.06.001. eCollection 2018 Jan.
•   Rolo AP, Palmeira CM
  Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress. Toxicol Appl Pharmacol. 2006 Apr 15;212(2):167-78. Epub 2006 Feb 20. Review.
•   Rybka J, Kedziora-Kornatowska K, Kupczyk D, Muszalik M, Kornatowski M, Kedziora J
  Antioxidant effect of immediate- versus sustained-release melatonin in type 2 diabetes mellitus and healthy controls. Drug Deliv. 2016;23(3):814-7. doi: 10.3109/10717544.2014.917343. Epub 2014 May 28.
•   Serrano R, García-Soidán FJ, Díaz-Redondo A, Artola S, Franch J, Díez J, Carrillo L, Ezkurra P, Millaruelo JM, Seguí M, Sangrós FJ, Martínez-Candela J, Muñoz P, Goday A, Regidor E; Grupo de Estudio PREDADS
  [Cohort Study in Primary Health Care on the Evolution of Patients with Prediabetes (PREDAPS): basis and methodology]. Rev Esp Salud Publica. 2013 Mar-Apr;87(2):121-35. doi: 10.4321/S1135-57272013000200003. English, Spanish.
•   Singh M, Jadhav HR
  Melatonin: functions and ligands. Drug Discov Today. 2014 Sep;19(9):1410-8. doi: 10.1016/j.drudis.2014.04.014. Epub 2014 Apr 30. Review.
•   Skrha J, Prázný M, Hilgertová J, Kvasnicka J, Kalousová M, Zima T
  Oxidative stress and endothelium influenced by metformin in type 2 diabetes mellitus. Eur J Clin Pharmacol. 2007 Dec;63(12):1107-14. Epub 2007 Sep 15.
•   Tang WH, Martin KA, Hwa J
  Aldose reductase, oxidative stress, and diabetic mellitus. Front Pharmacol. 2012 May 9;3:87. doi: 10.3389/fphar.2012.00087. eCollection 2012.
•   Thomas AP, Hoang J, Vongbunyong K, Nguyen A, Rakshit K, Matveyenko AV
  Administration of Melatonin and Metformin Prevents Deleterious Effects of Circadian Disruption and Obesity in Male Rats. Endocrinology. 2016 Dec;157(12):4720-4731. Epub 2016 Sep 21.
•   Torres-Bugarín O, Zavala-Cerna MG, Nava A, Flores-García A, Ramos-Ibarra ML
  Potential uses, limitations, and basic procedures of micronuclei and nuclear abnormalities in buccal cells. Dis Markers. 2014;2014:956835. doi: 10.1155/2014/956835. Epub 2014 Feb 4. Review.
•   Vecchio S, Giampreti A, Petrolini VM, Lonati D, Protti A, Papa P, Rognoni C, Valli A, Rocchi L, Rolandi L, Manzo L, Locatelli CA
  Metformin accumulation: lactic acidosis and high plasmatic metformin levels in a retrospective case series of 66 patients on chronic therapy. Clin Toxicol (Phila). 2014 Feb;52(2):129-35. doi: 10.3109/15563650.2013.860985. Epub 2013 Nov 28.
•   Wilson ML
  Prediabetes: Beyond the Borderline. Nurs Clin North Am. 2017 Dec;52(4):665-677. doi: 10.1016/j.cnur.2017.07.011. Epub 2017 Oct 5. Review.
•   Yang H, Jin X, Kei Lam CW, Yan SK
  Oxidative stress and diabetes mellitus. Clin Chem Lab Med. 2011 Nov;49(11):1773-82. doi: 10.1515/CCLM.2011.250. Epub 2011 Aug 3. Review.

Effect of the Administration of Melatonin and Metformin on Glycemic Control, Genotoxicity and Cytotoxicity Markers in Patients With Prediabetes: Pilot Study

Details for clinical trial NCT03848533